wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q39933767-D7C9E9EE-5B09-477E-8F93-ED03F3AD5C47
Q39933767-D7C9E9EE-5B09-477E-8F93-ED03F3AD5C47
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39933767-D7C9E9EE-5B09-477E-8F93-ED03F3AD5C47
Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer.
P2860
Q39933767-D7C9E9EE-5B09-477E-8F93-ED03F3AD5C47
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39933767-D7C9E9EE-5B09-477E-8F93-ED03F3AD5C47
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4d0634cb7ec62e0459cc4fc7d3ee5f35cd880797
P2860
Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer.